Surveillance of Small Renal Masses

Urology

Volumn 98, Issue , 2016, Pages 8-13

  Ahmad, Ardalan E ^a   Finelli, Antonio ^a   Jewett, Michael A S ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; DISEASE SURVEILLANCE; DISTANT METASTASIS; GENE EXPRESSION; GOLD STANDARD; HUMAN; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY TUMOR; LYMPHADENOPATHY; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PATIENT SELECTION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADICAL NEPHRECTOMY; REVIEW; SMALL RENAL MASS; TUMOR GROWTH; TUMOR THROMBUS; BIOPSY; CANCER REGISTRY; DIFFERENTIAL DIAGNOSIS; GLOBAL HEALTH; INCIDENCE; KIDNEY; PATHOLOGY; SURVIVAL RATE; TRENDS;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; GLOBAL HEALTH; HUMANS; INCIDENCE; KIDNEY; KIDNEY NEOPLASMS; SEER PROGRAM; SURVIVAL RATE;

EID: 84995598571     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2016.06.005     Document Type: Review

References (76)

1. 1 Siegel, R., Miller, K.D., Jemal, A., Cancer statistics. CA Cancer J Clin 65 (2015), 5–29.
2. 2 Ljungberg, B., Campbell, S.C., Choi, H.Y., et al. The epidemiology of renal cell carcinoma. Eur Urol 60 (2011), 615–621.
3. 3 Hollingsworth, J.M., Miller, D.C., Daignault, S., Hollenbeck, B.K., Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006), 1331–1334.
4. 4 Gill, I.S., Aron, M., Gevais, D.A., Jewett, M.A., Clinical practice. Small renal mass. N Engl J Med 362 (2010), 624–634.
5. 5 Hock, L.M., Lynch, J., Balaji, K.C., Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167 (2002), 57–60.
6. 6 Frank, I., Blute, M.L., Cheville, J.C., Lohse, C.M., Weaver, A.L., Zincke, H., Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:6 Pt 1 (2003), 2217–2220.
7. 7 Tsui, K.H., Shvarts, O., Smith, R.B., Figlin, R., de Kernion, J.B., Belldegrun, A., Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 163 (2000), 426–430.
8. 8 Rendon, R.A., Stanietzky, N., Panzarella, T., et al. The natural history of small renal masses. J Urol 164 (2000), 1143–1147.
9. 9 Licht, M.R., Novick, A.C., Goormastic, M., Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 152 (1994), 39–42.
10. 10 Hollenbeck, B.K., Taub, D.A., Miller, D.C., Dunn, R.L., Wei, J.T., National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?. Urology 67 (2006), 254–259.
11. 11 Huang, W.C., Levey, A.S., Serio, A.M., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7 (2006), 735–740.
12. 12 McKiernan, J., Simmons, R., Katz, J., Russo, P., Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002), 816–820.
13. 13 Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., Hsu, C.Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004), 1296–1305.
14. 14 Huang, W.C., Elkin, E.B., Levey, A.S., Jang, T.L., Russo, P., Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes?. J Urol 181 (2009), 55–61.
15. 15 Miller, D.C., Schonlau, M., Litwin, M.S., Lai, J., Saigal, C.S., Urologic Diseases in America Project. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 112 (2008), 511–520.
16. 16 Sun, M., Trinh, Q.D., Bianchi, M., et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 61 (2011), 725–731.
17. 17 Thompson, R.H., Boorjian, S.A., Lohse, C.M., et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179 (2008), 468–471.
18. 18 Weight, C.J., Lieser, G., Larson, B.T., et al. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 58 (2010), 293–298.
19. 19 Zini, L., Perrotte, P., Capitanio, U., et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 115 (2009), 1465–1471.
20. 20 Tan, H.J., Norton, E.C., Ye, Z., Hafez, K.S., Gore, J.L., Miller, D.C., Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 307 (2012), 1629–1635.
21. 21 Ljungberg, B., Bensalah, K., Canfield, S., et al. EAU Guidelines on renal cell carcinoma: the 2014 update. Eur Urol 67 (2015), 913–924.
22. 22 Martorana, G., Bertaccini, A., Concetti, S., et al. Nephron-sparing surgery for renal cell carcinoma: state of the art and 10 years of multicentric experience. Eur Urol Suppl 5 (2006), 600–609.
23. 23 MacLennan, S., Imamura, M., Lapitan, M.C., et al. EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localized renal cancer. Eur Urol 61 (2012), 972–993.
24. 24 Kim, S.P., Thompson, R.H., Boorjian, S.A., et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 188 (2012), 51–57.
25. 25 Corman, J.M., Penson, D.F., Hur, K., et al. Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program. BJU Int 86 (2000), 782–789.
26. 26 Gill, I.S., Schweizer, D., Hobart, M.G., Sung, G.T., Klein, E.A., Novick, A.C., Retroperitoneal laparoscopic radical nephrectomy: the Cleveland Clinic experience. J Urol 163 (2000), 1665–1670.
27. 27 Dunn, M.D., Portis, A.J., Shalhav, A.L., et al. Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol 164 (2000), 1153–1159.
28. 28 Portis, A.J., Yan, Y., Landman, J., et al. Long-term follow up after laparoscopic radical nephrectomy. J Urol 167 (2002), 1257–1262.
29. 29 Kutikov, A., Egleston, B.L., Wong, Y.N., Uzzo, R.G., Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28 (2010), 311–317.
30. 30 Kunkle, D.A., Egleston, B.L., Uzzo, R.G., Excise, ablate or observe: the small renal mass dilemma–a meta-analysis and review. J Urol 179 (2008), 1227–1233.
31. 31 Shuch, B., Hanley, J.M., Lai, J.C., et al. Adverse health outcomes associated with surgical management of the small renal mass. J Urol 191 (2014), 301–308.
32. 32 Volpe, A., Panzarella, T., Rendon, R.A., Haider, M.A., Kondylis, F.I., Jewett, M.A., The natural history of incidentally detected small renal masses. Cancer 100 (2004), 738–745.
33. 33 Abou Youssif, T., Kassouf, W., Steinberg, J., Aprikian, A.G., Laplante, M.P., Tanguay, S., Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110 (2007), 1010–1014.
34. 34 Mason, R.J., Abdolell, M., Trottier, G., et al. Growth kinetics of renal masses analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 59 (2011), 863–867.
35. 35 Brunocilla, E., Borghesi, M., Monti, C., Schiavina, R., Martorana, G., Surveillance for small renal masses: retrospective analysis of a cohort of 42 patients with long-term follow-up. Int Urol Nephrol 45 (2013), 307–312.
36. 36 Brunocilla, E., Borghesi, M., Schiavina, R., et al. Active surveillance for small renal masses diagnosed in elderly or comorbid patients: looking for the best treatment strategy. Actas Urol Esp 38 (2014), 1–6.
37. 37 Brunocilla, E., Borghesi, M., Schiavina, R., et al. Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. Clin Genitourin Cancer 12 (2014), 178–181.
38. 38 Gontero, P., Joniau, S., Oderda, M., et al. Active surveillance for small renal tumors: have clinical concerns been addressed so far?. Int J Urol 20 (2013), 356–361.
39. 39 Volpe, A., Jewett, M.A., The role of surveillance for small renal masses. Nat Clin Pract Urol 4 (2007), 2–3.
40. 40 Schmidbauer, J., Remzi, M., Memarsadeghi, M., et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53 (2008), 1003–1012.
41. 41 Lebret, T., Poulain, J.E., Molinie, V., et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178 (2007), 1184–1188.
42. 42 Volpe, A., Mattar, K., Finelli, A., et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 180 (2008), 2333–2337.
43. 43 Veltri, A., Garetto, I., Tosetti, I., et al. Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol 21 (2011), 393–401.
44. 44 Volpe, A., Kachura, J.R., Geddie, W.R., et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178 (2007), 379–386.
45. 45 Volpe, A., Finelli, A., Gill, I.S., et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62 (2012), 491–504.
46. 46 Richard, P.O., Jewett, M.A., Bhatt, J.R., et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol 68 (2015), 1007–1013.
47. 47 Herts, B.R., Baker, M.E., The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 13 (1995), 254–261.
48. 48 Marconi, L., Dabestani, S., Lam, T.B., et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69 (2016), 660–673, 10.1016/j.eururo.2015.07.072 Epub 2015 Aug 29.
49. 49 Jewett, M.A., Zuniga, A., Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am 35 (2008), 627–634.
50. 50 Kapur, P., Peña-Llopis, S., Christie, A., et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 14 (2013), 159–167.
51. 51 Rini, B., Goddard, A., Knezevic, D., et al. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. Lancet Oncol 16 (2015), 676–685.
52. 52 Mindrup, S.R., Pierre, J.S., Dahmoush, L., Konety, B.R., The prevalence of renal cell carcinoma diagnosed at autopsy. BJU Int 95 (2005), 31–33.
53. 53 Bell, E.T., A classification of renal tumors with observation of the frequency of the various types. J Urol 39 (1938), 238–243.
54. 54 Duffey, B.G., Choyke, P.L., Glenn, G., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172 (2004), 63–65.
55. 55 Bosniak, M.A., Observation of small incidentally detected renal masses. Semin Urol Oncol 13 (1995), 267–272.
56. 56 Jewett, M.A., Mattar, K., Basiuk, J., et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60 (2011), 39–44.
57. 57 Abouassaly, R., Lane, B.R., Novick, A.C., Active surveillance of renal masses in elderly patients. J Urol 180 (2008), 505–508.
58. 58 Rosales, J.C., Haramis, G., Moreno, J., et al. Active surveillance for renal cortical neoplasms. J Urol 183 (2010), 1698–1702.
59. 59 Crispen, P.L., Viterbo, R., Boorjian, S.A., Greenberg, R.E., Chen, D.Y., Uzzo, R.G., Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 115 (2009), 2844–2852.
60. 60 Remzi, M., Ozsoy, M., Klingler, H.C., et al. Are small renal tumors harmless? Analysis of histopathologic features according to tumors 4 cm or less in diameter. J Urol 176 (2006), 896–899.
61. 61 Friberg, S., Mattson, S., On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 65 (1997), 284–297.
62. 62 Chawla, S.N., Crispen, P.L., Hanlon, A.L., Greenberg, R.E., Chen, D.Y., Uzzo, R.G., The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006), 425–431.
63. 63 Kunkle, D.A., Crispen, P.L., Chen, D.Y., Greenberg, R.E., Uzzo, R.G., Enhancing renal masses with zero net growth during active surveillance. J Urol 177 (2007), 849–854.
64. 64 Van Poppel, H., Da Pozzo, L., Albrecht, W., et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59 (2011), 543–552.
65. 65 Lane, B.R., Abouassaly, R., Gao, T., et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 116 (2010), 3119–3126.
66. 66 Arrontes, D.S., Acenero, M.J., Gonzales, J.I., Munoz, M.M., Andres, P.P., Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 179 (2008), 857–861.
67. 67 Hollingsworth, J.M., Miller, D.C., Daignault, S., Hollenbeck, B.K., Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109 (2007), 1763–1768.
68. 68 Lughezzani, G., Sun, M., Budäus, L., Thuret, R., Perrotte, P., Karakiewicz, P.I., Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma. J Clin Oncol 28 (2010), e299–e300.
69. 69 Kutikov, A., Egleston, B.L., Canter, D., Smaldone, M.C., Wong, Y.N., Uzzo, R.G., Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188 (2012), 2077–2083.
70. 70 Pierorazio, P.M., Johnson, M.H., Ball, M.W., et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol 68 (2015), 408–415.
71. 71 Campbell, S.C., Novick, A.C., Belldegrun, A., et al. Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol 182 (2009), 1271–1279.
72. 72 Kim, S.P., Thompson, R.H., Approach to the small renal mass: to treat or not to treat. Urol Clin North Am 39 (2012), 171–179.
73. 73 Haramis, G., Mues, A.C., Rosales, J.C., et al. Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology 77 (2011), 787–791.
74. 74 Smaldone, M.C., Kutikov, A., Egleston, B.L., et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118 (2012), 997–1006.
75. 75 Crispen, P.L., Viterbo, R., Fox, E.B., Greenberg, R.E., Chen, D.Y., Uzzo, R.G., Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112 (2008), 1051–1057.
76. 76 Rais-Bahrami, S., Guzzo, T.J., Jarrett, T.W., Kavoussi, L.R., Allaf, M.E., Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int 103 (2009), 1355–1358.